(2012) Predicting future response to certolizumab pegol in rheumatoid arthritis patients: features at 12 weeks associated with low disease activity at 1 year - Curtis, J R; Luijtens, K; Kavanaugh, A (Arthritis Care Res (Hoboken), 2012)